The latest update of “Global Nuclear Medicine/Radiopharmaceuticals Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Nuclear Medicine/Radiopharmaceuticals Market.
Overview of the Nuclear Medicine/Radiopharmaceuticals Market:
Nuclear Medicine is a branch of medicine that uses radioactive substances to diagnose various diseases and conditions. It uses a special camera that detects the radioactivity of the tracer. The patient lies on a table for the imaging procedure. The doctor will then use a computer to analyze the radiation and see how the various organs of the body are functioning. These procedures are a great help to the medical community because they provide an accurate diagnosis of disease.
Market Dynamics:
Increasing number of nuclear medicine and molecular imaging centers is expected to propel growth of the global nuclear medicine/radiopharmaceuticals market over the forecast period. For instance, in December 2021, The Julius K. Quiambao Nuclear Medicine and Molecular Imaging Center was launched at The Medical City Clark, Philippines.
Asia Pacific is expected to witness significant growth in the global nuclear medicine/radiopharmaceuticals market, owing to government funding for nuclear medicine. For instance, in October 2021, The Australian Nuclear Science and Technology Organization announced to build US$ 30 million manufacturing facility for nuclear medicine.
Major players in the global nuclear medicine/radiopharmaceuticals market are focused on launching new products to enhance their market share. For instance, in May 2021, GE Healthcare launched Xeleris V – a new virtual processing and review solution with AI-enabled applications for precision health in nuclear medicine.
Major players in the global nuclear medicine/radiopharmaceuticals market are also focused on adopting various marketing strategies to enhance their market share. For instance, in June 2020, Lantheus Holdings, Inc. presented PyL (18F-DCFPyL), the PSMA-targeted small molecule positron emission tomography (PET) imaging investigational agent, at the virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting.
Key Takeaways:
- Increasing funding for nuclear medicine is expected to propel growth of the global nuclear medicine/radiopharmaceuticals market over the forecast period. For instance, in November 2020, The Development Bank of the Philippines signed a US$ 9.63 million term loan for Global Care Cancer Institute, Inc. to finance a cancer treatment facility in Bay, Laguna, which is also envisioned to be a nuclear medicine hub in the region.
- Major players in the global nuclear medicine/radiopharmaceuticals market are focused on adopting partnership strategies to enhance their market share. For instance, in March 2021, BWXT Medical Ltd. partnered with Global Medical Solutions, Ltd. for jointly manufacturing and distributing radioisotopes and radiopharmaceuticals in the Asia Pacific.
- Major players operating in the global nuclear medicine/radiopharmaceuticals market include, China Isotope & Radiation, ROTOP Pharmaka Ltd., Lantheus Holdings, Inc., Global Medical Solutions, Ltd., Innovation Pharma, NorthStar Medical Technologies, LLC, Dongcheng, Jaco, and Ciaeriar
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Nuclear Medicine/Radiopharmaceuticals Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Nuclear Medicine/Radiopharmaceuticals Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Nuclear Medicine/Radiopharmaceuticals Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
- Oncology
- Thyroid
- Cardiology
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Medicine/Radiopharmaceuticals Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Nuclear Medicine/Radiopharmaceuticals Market
1.6.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceuticals Market
1.6.1.1 Nuclear Medicine/Radiopharmaceuticals Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Nuclear Medicine/Radiopharmaceuticals Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Nuclear Medicine/Radiopharmaceuticals Market Perspective (2015-2028)
2.2 Nuclear Medicine/Radiopharmaceuticals Market Growth Trends by Regions
2.2.1 Nuclear Medicine/Radiopharmaceuticals Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Nuclear Medicine/Radiopharmaceuticals Market Historic Market Share by Regions (2015-2021)
2.2.3 Nuclear Medicine/Radiopharmaceuticals Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Nuclear Medicine/Radiopharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine/Radiopharmaceuticals Market Players by Market Size
3.1.1 Global Top Nuclear Medicine/Radiopharmaceuticals Market Players by Revenue (2015-2021)
3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio
3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceuticals Market Revenue in 2019
3.3 Nuclear Medicine/Radiopharmaceuticals Market Key Players Head office and Area Served
3.4 Key Players Nuclear Medicine/Radiopharmaceuticals Market Product Solution and Service
3.5 Date of entering into Nuclear Medicine/Radiopharmaceuticals Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Historic Market Size by Type (2015-2021)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Forecasted Market Size by Type (2021-2028)
5 Nuclear Medicine/Radiopharmaceuticals Market Breakdown Data by Application (2015-2028)
5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
5.2 Global Nuclear Medicine/Radiopharmaceuticals Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
6.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in North America (2019-2021)
6.3 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
6.4 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
7.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in Europe (2019-2021)
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
7.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
8 China
8.1 China Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
8.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in China (2019-2021)
8.3 China Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
8.4 China Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
9 Japan
9.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
9.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in Japan (2019-2021)
9.3 Japan Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
9.4 Japan Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
10.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
10.4 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
11 India
11.1 India Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
11.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in India (2019-2021)
11.3 India Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
11.4 India Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Size (2015-2021)
12.2 Nuclear Medicine/Radiopharmaceuticals Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021)
12.4 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Nuclear Medicine/Radiopharmaceuticals Market Introduction
13.4 Nuclear Medicine/Radiopharmaceuticals Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Nuclear Medicine/Radiopharmaceuticals Market Key Market Segments
Table 2. Key Players Covered: Ranking by Nuclear Medicine/Radiopharmaceuticals Market Revenue
Table 3. Ranking of Global Top Nuclear Medicine/Radiopharmaceuticals Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Nuclear Medicine/Radiopharmaceuticals Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Nuclear Medicine/Radiopharmaceuticals Market Players to Combat Covid-19 Impact
Table 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Regions (2015-2021)
Table 14. Global Nuclear Medicine/Radiopharmaceuticals Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Nuclear Medicine/Radiopharmaceuticals Market Growth Strategy
Table 20. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Market Players
Table 21. Global Nuclear Medicine/Radiopharmaceuticals Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Players (2015-2021)
Table 23. Global Top Nuclear Medicine/Radiopharmaceuticals Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals Market as of 2019)
Table 24. Global Nuclear Medicine/Radiopharmaceuticals Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Nuclear Medicine/Radiopharmaceuticals Market Product Solution and Service
Table 27. Date of entering into Nuclear Medicine/Radiopharmaceuticals Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 30. Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type (2015-2021)
Table 31. Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Market Share by Type (2021-2028)
Table 31. Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Application (2015-2021)
Table 33. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 34. Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Application (2021-2028)
Table 35. North America Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 37. North America Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 38. North America Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 39. North America Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 40. North America Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 41. Europe Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 43. Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 45. Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 47. China Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 49. China Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 50. China Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 51. China Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 52. China Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 53. Japan Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 55. Japan Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 57. Japan Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 61. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 63. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 65. India Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 67. India Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 68. India Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 69. India Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 70. India Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Nuclear Medicine/Radiopharmaceuticals Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Nuclear Medicine/Radiopharmaceuticals Market Share (2019-2021)
Table 73. Central & South America Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Nuclear Medicine/Radiopharmaceuticals Market Share by Type (2015-2021)
Table 75. Central & South America Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Nuclear Medicine/Radiopharmaceuticals Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Type: 2021 VS 2028
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Nuclear Medicine/Radiopharmaceuticals Market Report Years Considered
Figure 8. Global Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Regions: 2021 VS 2028
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Players in 2019
Figure 13. Global Top Nuclear Medicine/Radiopharmaceuticals Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceuticals Market Revenue in 2019
Figure 15. North America Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Nuclear Medicine/Radiopharmaceuticals Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
